Variables in the final model | Adjusted β coefficient (change in LINE-1 methylation level by a given variable) | 95% confidence limits | P value (partial F-test) |
---|---|---|---|
CIMP status | Â | Â | < 0.0001 |
CIMP-high (vs. CIMP-0) | 4.79 | 2.69, 6.89 | < 0.0001 (T test) |
CIMP-low (vs. CIMP-0) | 1.17 | -0.18, 2.52 | 0.090 (T test) |
Signet ring cell component (for 10% increase) | 1.15 | 0.53, 1.77 | 0.0003 |
Rectal location (vs. colon) | 2.22 | 0.68, 3.75 | 0.0046 |
Family history of colorectal cancer (present vs. absent) | -1.92 | -3.36, -0.48 | 0.0089 |
Disease stage (for one unit increase in ordinal scale, I-IV) | -0.83 | -1.50, -0.16 | 0.016 |
CDKN1A (p21) loss (vs. expression) | -2.06 | -3.75, -0.37 | 0.017 |
Crohn's-like reaction [for one unit increase in ordinal scale 1 (absent)-4 (strong)] | 1.26 | -0.20, 2.31 | 0.020 |
High tumor grade (vs. low grade) | -2.47 | -5.00, 0.07 | 0.056 |
Male (vs. female) | 1.03 | -0.24, 2.29 | 0.11 |
Body mass index (BMI, for an increase of 5 kg/m2) | 0.50 | -0.18, 1.18 | 0.15 |